Drug ID: | NPD2343 |
Drug Name: | |
Molecular Formula: | C17H14O3 |
Canonical SMILES: | OC(=O)C(c1cccc2c1occ2c1ccccc1)C |
Standard InCHI: | InChI=1S/C17H14O3/c1-11(17(18)19)13-8-5-9-14-15(10-20-16(13)14)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19) |
Standard InCHIKey: | ODZUWQAFWMLWCF-UHFFFAOYSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB002502 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 266.09 |
ALogP | -0.0991 |
MLogP | 3 |
XLogP | 5.187 |
HDA | 2 |
HBD | 1 |
Rotatable Bonds | 5 |
TPSA | 50.44 |
RO5 Violation | 1 |